RazorMetrics Achieves Major Recognition
RazorMetrics' growth driven by strong demand for prescription-drug savings and measurable ROI for plan sponsors
AUSTIN, Texas /PRNewswire/ -- RazorMetrics, a physician-directed technology company dedicated to improving prescription-drug affordability, has achieved notable recognition by ranking No. 12 on the 2025 Deloitte Technology Fast 500™. This prestigious list honors the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies across North America. Additionally, RazorMetrics garnered the No. 1 spot in the life sciences category in Texas and No. 2 nationwide. These rankings reflect the company's impressive percentage fiscal-year revenue growth from 2021 to 2024.
The remarkable triple-digit growth of RazorMetrics signifies a growing demand among health plans, employers, and brokers. They seek innovative, clinically sound, and data-driven methods to decrease prescription drug expenditures without disrupting existing provider workflows. The company's advanced technology plays a pivotal role in identifying safe and lower-cost therapeutic alternatives, allowing plan sponsors to minimize waste while simultaneously enhancing member trust and adherence to medications.
Tom Dorsett, CEO and Co-founder of RazorMetrics, expressed pride in this achievement, stating, "Ranking 12 on Deloitte's Technology Fast 500 is a tremendous honor for our entire team. Our growth can be directly attributed to our physician-first approach and the trusted outcomes we provide to our clients."
Dr. Siva Mohan, Co-founder and President of RazorMetrics, highlighted the escalating costs in healthcare, saying, "Prescription drug costs consistently rise at a pace faster than any other healthcare expense. By making it to Deloitte's Technology 500 list, we are validated in our commitment to making healthcare more affordable for our clients through innovative solutions."
In 2025, RazorMetrics bolstered its leadership team, scaled operations, and established broader partnerships to cater to the rising client demands. Recently, the company reported an impressive total of over $34 million saved in drug costs in Texas alone over a mere 24 months, demonstrating their capacity to deliver verified results effectively.
According to Wolfe Tone, US Deloitte Private & Emerging Client Portfolio leader at Deloitte Tax LLP, he stated, "This year’s rankings indicate a blend of enduring leadership alongside groundbreaking growth. Many awarded companies are previous honorees, yet most of the top ten are first-time entrants, showcasing the sustained influence of established players along with rapid advancements from new innovators. Private companies continue to excel in adapting to competitive markets, leading to the exceptional growth reflected in these rankings."
About RazorMetrics
RazorMetrics specializes in cutting-edge pharmacy cost containment solutions, enabling quick and effective reductions in medication costs. The proprietary technology of RazorMetrics automatically identifies cost-saving opportunities, such as medication switching and deprescribing, all while being tailored to fit clients' specific plans and formularies. This innovative approach seamlessly integrates into prescribers' existing workflows, enhancing healthcare decision-making while lowering medication costs for both members and plan sponsors. RazorMetrics proudly assists self-funded employers, health plans, pharmacy benefit managers, and various organizations in making pharmacy benefits clearer, more efficient, and more valuable.
About the 2025 Deloitte Technology Fast 500
Now celebrating its 31st year, the Deloitte Technology Fast 500 ranks the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. Award winners are determined based on their percentage fiscal-year revenue growth from 2021 to 2024. For eligibility, companies must possess proprietary intellectual property or technology that significantly contributes to their revenue, with minimum operating revenues of US$50,000 in the base year and at least US$5 million in the current year, alongside a minimum growth rate of 50%. Furthermore, eligible companies must be established for at least four years and be headquartered in North America.
Media Contact
Brynn Spicher
Anthony Barnum Public Relations
Frequently Asked Questions
What is RazorMetrics known for?
RazorMetrics is recognized for its innovative technology that improves prescription-drug affordability for users and plan sponsors.
What recent recognition did RazorMetrics receive?
RazorMetrics recently ranked No. 12 on Deloitte's Technology Fast 500, showcasing its significant growth in the tech industry.
How does RazorMetrics help in reducing prescription costs?
The company utilizes advanced technology to identify safe and lower-cost therapeutic alternatives, thereby reducing overall drug expenditures.
What are RazorMetrics' future plans?
RazorMetrics plans to continue expanding its leadership, scaling operations, and strengthening partnerships to meet growing client demands.
Where is RazorMetrics based?
RazorMetrics is based in Austin, Texas, where it delivers valuable pharmacy cost containment solutions.
